Skip to content

Lung Cancer Blog

Everything about lung cancer is here.

Menu
  • Home
  • About Us
  • Lung Cancer
    • Lung Cancer News
    • Causes of Lung Cancer
    • Lung Cancer Symptoms
    • Types of Lung Cancer
    • Stages of Lung Cancer
    • Lung Cancer Treatment
    • Lung Cancer Drugs
    • Lung Cancer In Ayurveda
    • Chinese Herbs For Lung Cancer
  • Researches
  • Studies
  • Stories
  • Sitemap
  • Contact Us
Menu
Alunbrig (brigatinib)

Drug: Alunbrig (Brigatinib) for Treatment of Lung Cancer

Posted on May 15, 2017
Post Views: 2,424

Alunbrig (brigatinib)Non-small cell lung cancer (NSCLC) is the most common type of lung cancer, making up 85% of new lung cancer cases in US every year. FDA has recently given approach to Alunbrig for rare form of lung cancer. This is developed by Takeda and is approved for treatment of patients with anaplastic lymphoma kinase-positive (ALK+) metastatic NSCLC. The approval was based on a non-comparative, open-label and multicenter clinical trial demonstrating clinically meaningful and durable ORR in patients. The patients had tumor and a total of 222 patients were randomized to brigatinib orally.

Brandon Tom, vice president, Biopharma Services, Biologics, Inc. said, “We are thrilled to have been given the privilege of being in this network of specialty pharmacies dispensing Alunbrig.” “Our team has decades of experience supporting NSCLC patients. We’re well prepared to help patients transition to this new therapy and to support them throughout their entire treatment journey,” he added.

Dosage

It is supplied as film-coated tablets having 30mg or 60mg of brigatinib. The recommended dose is 90mg once daily for the first seven days and then the dosage is increased to 180mg once daily. The pill can be taken with or without food.

The drug is manufactured by Takeda Pharmaceutical Company Limited. It is used to treat patients with NSCLC having a certain type of abnormal ALK gene and that has spread to other parts of the body and also those who have taken crizotinib but their condition worsened or they cannot tolerate taking the drug.

Side Effects

The most common adverse reactions taking brigatiib include nausea, diarrhea, cough, headache and fatigue. The serious ones included pneumonia and ILD/pneumonitis.  The patients should also be monitored for new or worsening respiratory problems such as hypertension, visual symptoms, blood glucose elevations and more.

Do you know anyone facing lung cancer? What problems do they face during lung cancer treatment? Let us know your thoughts in the comments.

 

The information offered in this blog is for informational purposes only and is not a substitute for medical advice.

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X
  • Click to share on Pinterest (Opens in new window) Pinterest
  • Click to share on WhatsApp (Opens in new window) WhatsApp
  • Click to share on Reddit (Opens in new window) Reddit
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to share on Tumblr (Opens in new window) Tumblr
  • Click to share on Pocket (Opens in new window) Pocket
  • Click to share on Telegram (Opens in new window) Telegram
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

Like this:

Like Loading...

Subscribe Us

Popular Articles

  • Lung Cancer Treatment in Ayurveda (7,303)
  • Lung Cancer: Symptoms and Treatment (5,625)
  • What is Non-Small-Cell Lung Cancer? (5,531)

Recent Comments

  • Lung Cancer on New Study To Help Advance Research In Lung Cancer
  • Laurie B Grimes on New Study To Help Advance Research In Lung Cancer
  • Lung Cancer on Asbestos and Lung Cancer – What’s The Link?

Recent Articles

  • FDA Grants Accelerated Approval to Telisotuzumab Vedotin-tllv for NSCLC May 19, 2025
  • Heart-Sparing Technique in Lung Cancer Radiotherapy May 12, 2025
  • Origins of Common Lung Cancer Linked to Smoking Discovered May 5, 2025
  • Lung Cancer Screening Is Beneficial For Non-Smokers As Well April 28, 2025
  • Understanding The Stage 0 Lung Cancer April 21, 2025

Lung Cancer Blog

Lung Cancer Blog provides all lung cancer related information for educational purposes.

Disclaimer

Some post may contain affiliate links, purchasing that product not going to cost extra but by your purchase Lung Cancer will get some little commission and that amount will help in surviving this website. So, please don’t hesitate to buy from these affiliate links.

Contact Us

If you have any query or suggestions about our blog, please feel free to email us at  lungcancersymptomsx@gmail.com.

Copyright © 2012 - 2025 Lung Cancer Blog. Wordpress by Vipasha.
%d